期刊文献+

循环肿瘤细胞在乳腺癌中的临床意义及检测方法

The clinical significance and detecting methods of circulating tumor cells in breast cancer
下载PDF
导出
摘要 乳腺癌预后的主要影响因素是术后复发和转移,而乳腺癌在肿瘤发展的早期就已经发生了转移,在乳腺癌外周血中发现肿瘤细胞,对早期诊断及治疗有指导意义。循环肿瘤细胞已经被证明是转移性乳腺癌预后的标志物。然而,最新研究表明循环肿瘤细胞在早期乳腺癌中亦可提示预后不良。目前,循环肿瘤细胞检测方法主要由富集分离法和分析鉴定法两部分组成,应选择合适的方法检测循环肿瘤细胞,以提高检测效率。探索循环肿瘤细胞与乳腺癌的关系,有助于乳腺癌早期检测及合理治疗。 Metastasis had been occurred in the early breast cancer,and the main influencing factors of prognosis were recurrence and metastasis after operation. So,monitoring tumor cells in peripheral blood was significance to diagnosis and treatment. Circulating tumor cells(CTC)have been shown to be a poor prognostic marker in metastatic breast cancer. However,several recent studies suggest that the presence of CTC in early breast cancer may also suggest a poorer prognosis. At present,the detection methods of circulating tumor cell were composed of enrichment separation and analysis identify methods. Choosing appropriate methods to detect circulating tumor cells could improve the efficiency of detection. Exploring the relation between circulating tumor cell and breast cancer may avail the early diagnosis and effective treatment of breast cancer.
作者 杨健 郝辉
机构地区 沧州市人民医院
出处 《基层医学论坛》 2015年第25期3535-3537,共3页 The Medical Forum
关键词 乳腺癌 微转移 循环肿瘤细胞 临床意义 检测方法 Breast cancer Metastasis Circulating tumor cells Clinical significance Detecting methods
  • 相关文献

参考文献21

  • 1Allard W J, Matera J, MillerMC, et al.Tumor cellscirculate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases[J].Clin Cancer Res, 2004,10(20) : 6897-6904.
  • 2Braun S, Vogl FD, Naume B,et al.A pooled analysis of bone marrow micrometastasis in breast cancer[J].N Engl JMed, 2005,353 ( 8 ) : 793-802.
  • 3Janni W, Rack B, Schindlbeck C, et al.The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence[J].Cancer, 2005,103(5 ) : 884-891.
  • 4DaskalakiA, Agelaki S, Perraki M,et al.Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone nmrrow of patients with operable breast cancer [J].British Journal of Cancer, 2009,101 (4) : 589-597.
  • 5Slade MJ,Payne R,Riethdorf S, et al.Comparison of bone marrow, disseminated tumour cells and blood-circulating tumour cells in breast cancer patients after primary treatment [J].British Journal of Cancer, 2009,100( 1 ) : 160-166.
  • 6Husemann Y, Geigl JB,Schubert F,et al.Systemic spread is an early step in breast cancer[J].Cancer Cell, 2008,13( 1 ) : 58-68.
  • 7Cristofanilli M, Budd GT, Ellis M J, et al.Circulating tumor cells, disease progression, and survival in metastatic breast cancer [J].N Engl J Med, 2004,351(8):781-791.
  • 8Ignatiadis M,Xenidis N,Perraki M,et al.Differentprognostic value of cytokeratin-19 mRNA positive circulating tumor ceils according to estrogen receptor andHER2 status in early-stage breast cancer[J].Clin Onco, 2007,25(33 ) : 5194-5202.
  • 9Dawood S, Broglio K,Valeroetal V.Circulating tumorcells in metastatic breast cancer: from prognostic stratification to modification of the staging system[J].Cancer, 2008, I 13 ( 9 ) : 2422-2430.
  • 10Tewes M, Aktas B,Welt A, et al.Molecular prof'fling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies[J].Breast Cancer Research and Treatment, 2009,115(3) : 581-590.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部